REGN5459
Regeneron
['multiplemyeloma', 'regn5459']
regn5459, a bispecific antibody targeting bcma and cd3, elicited a high overall response rate at the recommended phase ii dose in patients with relapsed or refractory #multiplemyeloma. #aacr23
The mission of the American Association for Cancer Research is to prevent and cure cancer through research, education, communication, and collaboration.